Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 2
1958 1
1959 1
1962 1
1963 1
1966 1
1970 1
1973 2
1975 2
1978 3
1979 1
1981 2
1982 1
1983 2
1984 3
1985 10
1986 10
1987 12
1988 12
1989 17
1990 8
1991 15
1992 16
1993 12
1994 19
1995 23
1996 31
1997 41
1998 49
1999 58
2000 82
2001 92
2002 112
2003 169
2004 171
2005 234
2006 315
2007 332
2008 367
2009 431
2010 499
2011 541
2012 619
2013 734
2014 689
2015 814
2016 766
2017 780
2018 802
2019 869
2020 912
2021 936
2022 887
2023 221
Text availability
Article attribute
Article type
Publication date

Search Results

11,192 results
Results by year
Filters applied: . Clear all
Page 1
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.
Dubrot J, Du PP, Lane-Reticker SK, Kessler EA, Muscato AJ, Mehta A, Freeman SS, Allen PM, Olander KE, Ockerman KM, Wolfe CH, Wiesmann F, Knudsen NH, Tsao HW, Iracheta-Vellve A, Schneider EM, Rivera-Rosario AN, Kohnle IC, Pope HW, Ayer A, Mishra G, Zimmer MD, Kim SY, Mahapatra A, Ebrahimi-Nik H, Frederick DT, Boland GM, Haining WN, Root DE, Doench JG, Hacohen N, Yates KB, Manguso RT. Dubrot J, et al. Among authors: kim sy. Nat Immunol. 2022 Oct;23(10):1495-1506. doi: 10.1038/s41590-022-01315-x. Epub 2022 Sep 23. Nat Immunol. 2022. PMID: 36151395
Update on Biliary Cancer Imaging.
Kim DW, Kim SY, Yoo C, Hwang DW. Kim DW, et al. Among authors: kim sy. Radiol Clin North Am. 2022 Sep;60(5):825-842. doi: 10.1016/j.rcl.2022.05.001. Epub 2022 Jul 12. Radiol Clin North Am. 2022. PMID: 35989047 Review.
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial.
Sung KC, Sung JH, Cho EJ, Ahn JC, Han SH, Kim W, Kim KH, Sohn IS, Shin J, Kim SY, Kim KI, Kang SM, Park SJ, Kim YJ, Shin JH, Park SM, Park CG. Sung KC, et al. Among authors: kim sy. J Clin Hypertens (Greenwich). 2022 Oct;24(10):1298-1309. doi: 10.1111/jch.14570. Epub 2022 Sep 12. J Clin Hypertens (Greenwich). 2022. PMID: 36094783 Free PMC article. Clinical Trial.
Dual-channel P-type ternary DNTT-graphene barristor.
Lee Y, Kim SM, Kim K, Kim SY, Lee HI, Kwon H, Lee HW, Kim C, Some S, Hwang HJ, Lee BH. Lee Y, et al. Among authors: kim sy. Sci Rep. 2022 Nov 12;12(1):19423. doi: 10.1038/s41598-022-23669-w. Sci Rep. 2022. PMID: 36371420 Free PMC article.
Photoswitchable Microgels for Dynamic Macrophage Modulation.
Kim Y, Thangam R, Yoo J, Heo J, Park JY, Kang N, Lee S, Yoon J, Mun KR, Kang M, Min S, Kim SY, Son S, Kim J, Hong H, Bae G, Kim K, Lee S, Yang L, Lee JY, Kim J, Park S, Kim DH, Lee KB, Jang WY, Kim BH, Paulmurugan R, Cho SW, Song HC, Kang SJ, Sun W, Zhu Y, Lee J, Kim HJ, Jang HS, Kim JS, Khademhosseini A, Kim Y, Kim S, Kang H. Kim Y, et al. Among authors: kim sy. Adv Mater. 2022 Dec;34(49):e2205498. doi: 10.1002/adma.202205498. Epub 2022 Nov 2. Adv Mater. 2022. PMID: 36268986
USP37 Deubiquitinates CDC73 in HPT-JT Syndrome.
Kim SY, Lee JY, Cho YJ, Jo KH, Kim ES, Han JH, Baek KH, Moon SD. Kim SY, et al. Int J Mol Sci. 2022 Jun 7;23(12):6364. doi: 10.3390/ijms23126364. Int J Mol Sci. 2022. PMID: 35742816 Free PMC article.
Reflex of the Gracilis in Brain Death.
Ryu HU, Kim SY, Kang HG. Ryu HU, et al. Among authors: kim sy. Diagnostics (Basel). 2022 Oct 7;12(10):2422. doi: 10.3390/diagnostics12102422. Diagnostics (Basel). 2022. PMID: 36292110 Free PMC article.
11,192 results
You have reached the last available page of results. Please see the User Guide for more information.